SCHEMBL4907182

SCHEMBL4907182

Cc1ccc(S(=O)(=O)NCCc2nc(-c3ccc(C(C)(C)C)cc3)sc2C)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.46
ALDH1A1 P00352 3/20 0.43
HTT P42858 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 6/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 5/20 0.41
THRB P10828 1/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
NR1H4 Q96RI1 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905581 0.92 LMNA (0.46) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL4906242 0.92 LMNA (0.42) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL4906394 0.91 LMNA (0.41) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL4901452 0.91 LMNA (0.49) LMNAALDH1A1HTTMAPTMEN1
SCHEMBL4907494 0.90 LMNA (0.40) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL4904339 0.90 LMNA (0.55) LMNAALDH1A1HTTMAPTKDM4E
SCHEMBL4906194 0.90 MAPT (0.42) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL4902495 0.89 LMNA (0.48) LMNAMAPTTP53
SCHEMBL4904282 0.89 LMNA (0.48) LMNAMAPTKMT2ATP53THRB
SCHEMBL4903589 0.87 PPARA (0.49) LMNAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885ALDH1A1 2664/4885HTT 711/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HTT 696/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HTT 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.